Nephros, Inc. (NEPH)
NASDAQ: NEPH · Real-Time Price · USD
3.460
-0.090 (-2.54%)
At close: Aug 1, 2025, 4:00 PM
3.410
-0.050 (-1.45%)
After-hours: Aug 1, 2025, 4:10 PM EDT
Six Flags Entertainment Revenue
Nephros had revenue of $4.88M in the quarter ending March 31, 2025, with 38.47% growth. This brings the company's revenue in the last twelve months to $15.52M, up 10.34% year-over-year. In the year 2024, Nephros had annual revenue of $14.16M, down -0.53%.
Revenue (ttm)
$15.52M
Revenue Growth
+10.34%
P/S Ratio
2.33
Revenue / Employee
$500,548
Employees
31
Market Cap
36.25M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 14.16M | -76.00K | -0.53% |
Dec 31, 2023 | 14.24M | 4.26M | 42.74% |
Dec 31, 2022 | 9.98M | -242.00K | -2.37% |
Dec 31, 2021 | 10.22M | 1.66M | 19.34% |
Dec 31, 2020 | 8.56M | -1.77M | -17.16% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
NEPH News
- 2 days ago - Nephros Schedules Second Quarter 2025 Financial Results Conference Call - GlobeNewsWire
- 8 months ago - Nephros to Participate in the Benchmark Company Annual Discovery One-on-One Investor Conference on December 11, 2024 in NYC - GlobeNewsWire
- 9 months ago - Nephros, Inc. (NEPH) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 9 months ago - Nephros Schedules Third Quarter 2024 Financial Results Conference Call - GlobeNewsWire
- 10 months ago - Nephros Delivers Critical Disaster Response to Support Hospitals and Care Facilities Impacted by Hurricanes Helene and Milton - GlobeNewsWire
- 1 year ago - Nephros, Inc. (NEPH) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 1 year ago - Nephros Announces Financial Results for Quarter Ended June 30, 2024 - GlobeNewsWire
- 1 year ago - Nephros Schedules Second Quarter 2024 Financial Results Conference Call - GlobeNewsWire